Apyx Medical Corp - Common Stock (APYX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
APYX on Nasdaq
Shares outstanding
41,059,412
Price per share
$3.50
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
15,737,051
Total reported value
$33,674,427
% of total 13F portfolios
0%
Share change
-94,064
Value change
-$213,867
Number of holders
47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apyx Medical Corp - Common Stock (APYX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 10% $3,178,844 3,493,235 Nantahala Capital Management, LLC 31 Dec 2024
ROYCE & ASSOCIATES LP 6% $8,550,622 2,443,035 ROYCE & ASSOCIATES LP 31 Dec 2025

As of 30 Sep 2025, 47 institutional investors reported holding 15,737,051 shares of Apyx Medical Corp - Common Stock (APYX). This represents 38% of the company’s total 41,059,412 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Apyx Medical Corp - Common Stock (APYX) together control 38% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 8.1% 3,338,048 0% 0.44% $7,143,423
Archon Capital Management LLC 8% 3,281,486 0% 4.2% $7,022,380
ROYCE & ASSOCIATES LP 6% 2,474,399 +1.4% 0.05% $5,295,214
VANGUARD GROUP INC 3.7% 1,528,947 +3.6% 0% $3,271,947
Silverberg Bernstein Capital Management LLC 2.4% 986,503 +10% 1.3% $2,111,204
COMMONWEALTH EQUITY SERVICES, LLC 1.6% 663,541 0% 0% $1,420,000
HORIZON KINETICS ASSET MANAGEMENT LLC 1.5% 615,000 0% 0.02% $1,316,100
BlackRock, Inc. 1.2% 509,763 +1.3% 0% $1,090,893
Taylor Frigon Capital Management LLC 1.1% 470,652 -1.7% 0.5% $1,007,195
GEODE CAPITAL MANAGEMENT, LLC 0.86% 351,278 +0.47% 0% $751,918
RENAISSANCE TECHNOLOGIES LLC 0.54% 221,697 +22% 0% $474,432
Kingsview Wealth Management, LLC 0.47% 193,043 +0.75% 0.01% $413,112
PERCEPTIVE ADVISORS LLC 0.37% 150,000 0% 0.01% $321,000
Caption Management, LLC 0.3% 123,932 +15% 0.02% $265,214
STATE STREET CORP 0.27% 109,306 0% 0% $233,915
NORTHERN TRUST CORP 0.26% 106,806 -10% 0% $228,565
PERKINS CAPITAL MANAGEMENT INC 0.2% 81,000 -64% 0.15% $173,340
RPg Family Wealth Advisory, LLC 0.19% 76,250 0.04% $163,175
Private Advisor Group, LLC 0.16% 66,720 -77% 0% $142,781
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.15% 61,601 0% 0% $131,826
SALEM INVESTMENT COUNSELORS INC 0.11% 45,500 0% $97,370
FRANKLIN RESOURCES INC 0.07% 27,489 0% $58,826
DIMENSIONAL FUND ADVISORS LP 0.06% 24,664 -67% 0% $52,781
GREENWOOD CAPITAL ASSOCIATES LLC 0.06% 22,789 0% 0.01% $48,768
XTX Topco Ltd 0.05% 21,545 0% $46,106

Institutional Holders of Apyx Medical Corp - Common Stock (APYX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,089,503 $3,813,261 +$162,750 $3.50 4
2025 Q3 15,737,051 $33,674,427 -$213,867 $2.14 47
2025 Q2 15,811,115 $35,574,319 +$288,225 $2.25 39
2025 Q1 15,792,917 $21,635,134 -$202,681 $1.37 43
2024 Q4 15,925,107 $25,160,336 +$4,988,209 $1.58 45
2024 Q3 12,800,031 $15,871,504 -$371,477 $1.24 45
2024 Q2 13,089,462 $17,538,939 -$313,631 $1.34 49
2024 Q1 13,334,937 $18,134,845 -$10,597,896 $1.36 51
2023 Q4 17,452,702 $45,730,029 -$5,190,379 $2.62 62
2023 Q3 18,328,200 $58,651,537 -$229,028 $3.20 61
2023 Q2 18,770,221 $94,412,555 -$2,505,631 $5.03 55
2023 Q1 20,085,109 $58,156,535 +$5,918,433 $2.88 54
2022 Q4 18,191,340 $42,568,844 -$7,872,047 $2.34 48
2022 Q3 20,926,665 $93,963,141 -$1,016,635 $4.49 53
2022 Q2 21,031,854 $123,244,150 +$8,066,381 $5.86 61
2022 Q1 19,582,685 $127,931,812 -$1,520,009 $6.53 70
2021 Q4 19,106,864 $244,910,256 -$2,633,464 $12.82 74
2021 Q3 18,881,855 $261,278,213 +$1,837,936 $13.85 74
2021 Q2 19,074,530 $196,570,403 +$519,685 $10.31 73
2021 Q1 18,975,246 $183,295,913 +$4,233,889 $9.66 67
2020 Q4 18,563,287 $133,715,214 +$4,919,670 $7.20 63
2020 Q3 17,818,092 $83,924,627 -$799,192 $4.71 59
2020 Q2 18,132,429 $100,699,990 +$1,987,743 $5.55 60
2020 Q1 17,698,113 $63,538,783 -$3,782,110 $3.59 64
2019 Q4 18,252,816 $154,427,344 +$472,016 $8.46 68
2019 Q3 17,769,394 $120,273,837 +$8,067,427 $6.77 67
2019 Q2 17,318,462 $116,360,053 +$14,336,984 $6.72 66
2019 Q1 15,330,673 $96,737,645 +$87,019,958 $6.31 77
2018 Q4 924,973 $5,994,000 +$5,994,000 $6.48 2